Pharma Companies File 15% of Patents in India

Dec 2022

The Indian Pharma industry is primarily known for its Generic Drugs. But recently, to push its value higher in the market, the Indian pharmaceutical industry is investing more in research and development of new drugs along with increasing the potency of the existing ones to move up the value chain.

From 2013-2015, out of the 1.3 lakhs patent submitted for a certain drug, more than 15% of the total amount was filed in India as per the report issued by Clarivate Analytics.

The Indian Pharmaceutical companies have witnessed a steady growth of their industry in the past few years which have eventually helped thousands of companies to grow. The reason behind this can be the flexibility of the government and minimized competition from the overseas market.

Now, the industry is forced to reopen its business models and long term strategies as it enters the global trade market. And due to this rising competition, the protection of the intellectual proper is also increasing at the same time.

Constant efforts are being made to curb the weak enforceability of the patents. Now, the Indian government is working towards introducing a new patent law that will consider the technological advancement a factor along with staying in par with the global market.

Concerning pharmaceuticals, on account of substances planned for utilize or equipped for being utilized as nourishment, medications or meds or substances created by compound procedures, licenses are conceded uniquely for the procedures of assembling of such substances and not for the substances themselves. Thus, pharmaceutical items are right now not allowed patent assurance under Indian law.

India had an item patent system for all innovations under the Patents and Designs Act 1911. Be that as it may, in 1970, the legislature presented the new Patents Act, which rejected pharmaceuticals and agrochemical items from qualification for licenses.

This prohibition was acquainted with split away India’s reliance on imports for mass medications and definitions and accommodate advancement of a confident indigenous pharmaceutical industry.

Recently, the Indian pharmaceutical industry has signed a contract with as many as 55 research organizations along with multination pharmaceuticals companies in terms of drug development, M&A deals, and drug manufacturing supply, drug development and commercialisation of the drug.

As of now, the industry is focusing more on manufacturing drugs for diabetes, epilepsy, dermatology, antibacterial, inflammation along with multiple infection variants as well as oncology.

Trending Blogs
Pharma Companies File 15% of Patents in India
The Indian Pharma industry is primarily known for its Generic Drugs. But recently, to push its value higher in the market, the Indian pharmaceutical industry is investing more in research and development of new drugs along with increasing the potency of the existing ones to move up the value chain. From 2013-2015, out of the […]
Read More
Evaluation Intellectual Property Rights
Intellectual property has always existed since the dawn of time but there were no laws in place for their protection. Intellectual property is intangible asset, be it music, creative writing, arts, discoveries, inventions and development of unique words, symbols and artwork. Intellectual property rights is a generic term that covers copyright, industrial design, trade secrets, […]
Read More
Lack of Music Publishing Knowledge Robbing Indian Artists of their Rights
In India there has been a lack of knowledge regarding publishing music. It can be said that a large part of publishing an art for is still unexplored. It is not about the common people but the artists and the music companies are oblivious towards it. At the initial stage due to lack of knowledge […]
Read More
Protection of Acronyms under Trademark Law
It is known that acronyms are the first letters of a long phrase of words combined together. On the other hand, trademark is about a mark that shall help distinguish the product or service of goods or service from the rest of the items. Therefore, it can be said that an acronym can be registered […]
Read More
Blockchain Technology: Is it Building a Brighter Future
What is Blockchain Technology? The Blockchain is an incorruptible digital ledger of transactions that can be programmed to record virtually everything of value. So a blockchain is a continuously growing list of records called blocks, which are linked and secured. It protects the identities of the users. Although transactions on the blockchain are not completely […]
Read More
Intellectual Property Glance
The discussion on intellectual property starts with distributing it into three categories for the same of convenience and clarity. The product of intellectual efforts: The product of intellectual effort could be tangible or intangible encompassing such outcomes as literary creations, artistic creations, books, music, song, dance, drama, sculpture, paintings and even computer programs. It must […]
Read More
The Big Push to Reform Music Copyright for the Digital Age
Music creators of the present digital age should be aware of the copyright issues better due to different reasons. Music is made available on different websites, and it is necessary to prevent the increasing problem of infringement. Pertaining to this, a number of bills are proposed in Congress that can enhance royalty payment for the […]
Read More
Need for Kashmiri Saffron to get the GI tag
The Kashmiri Saffron has been given geographical indication tag recently from Lieutenant Governor G C Murmu. The acquiring of GI tag is a step ahead in bringing the brand among the list of top ones. The tag has been given for the saffron grown in Kashmir. In this regard, it can be said that the […]
Read More
Domain Name Disputes in India
Domain Name As Trademarks A domain name which is unique, capable of identifying itself and distinguishing its goods and services from those of others and acts as a reliable source identifier of concerned goods and services on the internet may be registered as a trademark. Domain Name Disputes A domain name dispute would arise when […]
Read More
PTAB Should Not Disapprove Claims on the Grounds of Indefiniteness in IPR
Federal Circuit has disapproved of arguments of claims that show any reason other than anticipation pertaining to party procedures. Federal Circuit has rejected the challenge shown by Samsung Electronics America, Inc. The company challenged that PTAB can disapprove claims that are considered indefinite in IPR. Samsung has been charged on the grounds of infringing U.S. […]
Read More
X
Download Firm Profile